FRANCISCO JOSE
HERMIDA PRADO
Investigador
JUANA MARIA
GARCIA PEDRERO
Investigador/a
Publicaciones en las que colabora con JUANA MARIA GARCIA PEDRERO (26)
2024
-
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
Journal of translational medicine, Vol. 22, Núm. 1, pp. 135
2023
-
Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics
Biomedicine and Pharmacotherapy, Vol. 158
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
Cancer research, Vol. 83, Núm. 19, pp. 3284-3304
-
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
Pathobiological functions and clinical implications of annexin dysregulation in human cancers
Frontiers in Cell and Developmental Biology, Vol. 10
2021
-
Tumor-infiltrating cd20+ b lymphocytes: Significance and prognostic implications in oral cancer microenvironment
Cancers, Vol. 13, Núm. 3, pp. 1-16
2020
-
Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
2019
-
Deciphering the molecular basis of melatonin protective effects on breast cells treated with doxorubicin: Twist1 a transcription factor involved in emt and metastasis, a novel target of melatonin
Cancers, Vol. 11, Núm. 7
-
SOX2 expression is an independent predictor of oral cancer progression
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
-
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma
Cancers, Vol. 11, Núm. 11
-
The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions
Cancers, Vol. 11, Núm. 3
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2018
-
Analysis of invasive activity of CAF spheroids into three dimensional (3D) collagen matrices
Methods in Molecular Biology (Humana Press Inc.), pp. 145-154
-
Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients
Journal of Clinical Medicine, Vol. 7, Núm. 12
-
FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway
Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56